W.L.Gore & Associates   Report issue

For profit Phase 2 Phase 3
Founded: Newark NJ United States (1958)
Status: No NME R&D (1958)

Organization Overview

First Clinical Trial
2020
NCT04100135
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Avobis Bio, LLC | W.L.Gore & Associates